Combined modality treatment of Ewing's sarcoma of the maxilla
β Scribed by Leonard H. Wexler; Ashutosh Kacker; John D. Piro; Joseph Haddad Jr; Lanny G. Close
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 161 KB
- Volume
- 25
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background.
Primary bone sarcomas arising in osseous structures of the head and neck are rare. These tumors are often incompletely resected and treated with radiotherapy for local control.
Methods.
We report a case of a 9βyearβold girl with a maxillary Ewing's sarcoma. This patient was successfully treated with neoadjuvant chemotherapy followed by surgical resection and prosthetic reconstruction of the primary site. The surgical approach that was used consisted of a subtotal maxillectomy by means of a facial degloving approach, sparing the orbital contents and the inferior orbital rim and orbital floor.
Results.
This approach produced excellent cosmetic, functional, and oncologic outcome. The patient remains without evidence of disease recurrence more than 4 years after surgery.
Conclusions.
This case illustrates a novel surgical approach to the resection of a maxillary Ewing's sarcoma and highlights the need for a multidisciplinary team approach to the management of head and neck sarcomas in children. Β© 2003 Wiley Periodicals, Inc. Head Neck 25: 168β172, 2003
π SIMILAR VOLUMES
## Abstract ## Background and Objectives Local therapy of pelvic Ewing's sarcoma remains a challenge because of the complex anatomy and large tumor volumes. Wide resections often end up contaminated with marginal margins in one part of the specimen. Pelvic tumor surgery causes considerable disabil
## BACKGROUND. The treatment of Ewing's sarcoma consists of chemotherapy for systemic and local disease. However, the role of radiation therapy, and/or surgical resection for definitive local treatment has yet to be determined. ## METHODS. A retrospective review of 32 patients (24 males and 8 f
Twelve patients with metastatic Ewing's sarcoma, ranging in age from 4 to 26 years, were treated with l-3-bis chloroethyl nitrosourea (BCNU). The tumor in five of the patients showed objective tumor shrinkage with BCNU. In one patient, there was complete disappearance of the tumor lasting 2% years.